Citadel Advisors’s Baird Medical Investment Holdings BDMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$63.1K Buy
+54,895
New +$85.3K ﹤0.01% 12999
2026
Q1
Sell
-112,660
Closed -$153K 14548
2025
Q4
$153K Buy
112,660
+66,128
+142% +$96.2K ﹤0.01% 11293
2025
Q3
$98.6K Buy
+46,532
New +$119K ﹤0.01% 11858

Other funds holding BDMD

Citadel Advisors's BDMD Position: Q2 2026 in Review

Citadel Advisors opened a new position in Baird Medical Investment Holdings (BDMD) in Q2 2026: 54,895 shares worth $63.1K. The stake represents ﹤0.01% of the portfolio and ranks #12999 among its holdings. This is a return to the name: Citadel Advisors previously reported a position in BDMD as recently as Q4 2025.

Citadel Advisors first reported a position in BDMD in Q3 2025 and has held it in 3 quarters since. The position peaked at $153K in Q4 2025. 10 funds tracked by Wall St. Rank hold BDMD as of Q2 2026.

  • Citadel Advisors held 54,895 shares of Baird Medical Investment Holdings worth $63.1K as of Q2 2026.
  • Baird Medical Investment Holdings was a new Citadel Advisors position in Q2 2026.
  • Baird Medical Investment Holdings made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #12999 holding.
  • Citadel Advisors first reported a position in Baird Medical Investment Holdings in Q3 2025 and has held it in 3 quarters since.
  • Citadel Advisors's Baird Medical Investment Holdings position peaked at $153K in Q4 2025.
  • 10 funds tracked by Wall St. Rank held Baird Medical Investment Holdings as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.